Industry: Pharmaceuticals, Biotechnology
Procognia Ltd, a 2004 World Economic Forum Technology Pioneer award winner, is focused on developing and commercializing its cutting edge proprietary technologies to enable the unraveling of disease mechanisms and the discovery and development of drugs to treat those diseases. In addition to developing its glycoanalysis technology, Procognia has developed arrays of biologically related proteins that retain their physiological function in the array format. Procognia was formed in April 2002 with a corporate headquarters and manufacturing in Maidenhead, United Kingdom. Commercial operations are run from the United Kingdom and Exton, PA, United States, and supported by R&D facilities in Maidenhead, United Kingdom and Ashdod, Israel. ( www.procognia.com )
Procognia Limited
Procognia Limited Unit 4, The Switchback Gardner Road
Maidenhead, Berkshire SL6 7RJ
United Kingdom
Tel: +44 1628 513500
Fax: +44 1628 676791